Literature DB >> 8541032

Intrastrain differences in Helicobacter pylori: a key question in mucosal damage?

M J Blaser1.   

Abstract

Helicobacter pylori causes persistent infection and inflammation in the human stomach, yet only a small fraction of infected people develop illness. An important question is why this diversity exists in infection outcome. In recent years, there has been evidence of substantial phenotypic as well as genotypic diversity of H. pylori. Three different phenotypes--production of vacuolating cytotoxin, presence of cagA, and ability for strong PMN activation--appear to be linked to one another and to the propensity for a H. pylori strain to cause peptic ulcer disease. Further investigation in this field may help to define which infected people bear the highest risk for serious clinical consequences, and ultimately to define optimal vaccine candidates and strategies.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8541032     DOI: 10.3109/07853899509002469

Source DB:  PubMed          Journal:  Ann Med        ISSN: 0785-3890            Impact factor:   4.709


  22 in total

1.  Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection.

Authors:  J Parsonnet; G D Friedman; N Orentreich; H Vogelman
Journal:  Gut       Date:  1997-03       Impact factor: 23.059

2.  The efficacy of laboratory diagnosis of Helicobacter pylori infections in gastric biopsy specimens is related to bacterial density and vacA, cagA, and iceA genotypes.

Authors:  L J van Doorn; Y Henskens; N Nouhan; A Verschuuren; R Vreede; P Herbink; G Ponjee; K van Krimpen; R Blankenburg; J Scherpenisse; W Quint
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

3.  Typing of Helicobacter pylori vacA gene and detection of cagA gene by PCR and reverse hybridization.

Authors:  L J van Doorn; C Figueiredo; R Rossau; G Jannes; M van Asbroek; J C Sousa; F Carneiro; W G Quint
Journal:  J Clin Microbiol       Date:  1998-05       Impact factor: 5.948

4.  Distinct variants of Helicobacter pylori cagA are associated with vacA subtypes.

Authors:  L J van Doorn; C Figueiredo; R Sanna; M J Blaser; W G Quint
Journal:  J Clin Microbiol       Date:  1999-07       Impact factor: 5.948

5.  Helicobacter pylori-associated gastritis in mice is host and strain specific.

Authors:  N E van Doorn; F Namavar; M Sparrius; J Stoof; E P van Rees; L J van Doorn; C M Vandenbroucke-Grauls
Journal:  Infect Immun       Date:  1999-06       Impact factor: 3.441

6.  Diversity of Helicobacter Pylori cagA and vacA Genes and Its Relationship with Clinical Outcomes in Azerbaijan, Iran.

Authors:  Reza Ghotaslou; Morteza Milani; Mohammad Taghi Akhi; Mohammad Reza Nahaei; Alka Hasani; Mohammad Saeid Hejazi; Mohammad Meshkini
Journal:  Adv Pharm Bull       Date:  2013-02-07

7.  Analysis of Helicobacter pylori genotypes in Afghani and Iranian isolates.

Authors:  Hossein Dabiri; Mehdi Bolfion; Akbar Mirsalehian; Maryam Rezadehbashi; Fereshteh Jafari; Leila Shokrzadeh; Navid Sahebekhtiari; Homayon Zojaji; Yoshio Yamaoka; Darioush Mirsattari; Mohammad Reza Zali
Journal:  Pol J Microbiol       Date:  2010

8.  Expanding allelic diversity of Helicobacter pylori vacA.

Authors:  L J van Doorn; C Figueiredo; R Sanna; S Pena; P Midolo; E K Ng; J C Atherton; M J Blaser; W G Quint
Journal:  J Clin Microbiol       Date:  1998-09       Impact factor: 5.948

9.  Distribution of Helicobacter pylori cagA, cagE, oipA and vacA in different major ethnic groups in Tehran, Iran.

Authors:  Hossein Dabiri; Parviz Maleknejad; Yoshio Yamaoka; Mohammad M Feizabadi; Fereshteh Jafari; Maryam Rezadehbashi; Farrokh A Nakhjavani; Akbar Mirsalehian; Mohammad R Zali
Journal:  J Gastroenterol Hepatol       Date:  2009-08       Impact factor: 4.029

10.  Helicobacter pylori stimulates inducible nitric oxide synthase in diverse topographical patterns in various gastroduodenal disorders.

Authors:  Mitsuru Kaise; Jun Miwa; Kuniko Iihara; Nobuaki Suzuki; Yoshio Oda; Yasuhiko Ohta
Journal:  Dig Dis Sci       Date:  2003-04       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.